Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of ReShape Lifesciences Inc. from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ReShape Lifesciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2019 to Q1 2024.
  • ReShape Lifesciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending March 31, 2024 was $59K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)

ReShape Lifesciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2024 $59K Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $59K Dec 31, 2023 10-K 2024-04-01
Q3 2023 $59K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $59K Jun 30, 2023 10-Q 2023-08-07
Q1 2021 $108K -$153K -58.6% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $105K -$12K -10.3% Dec 31, 2020 10-K 2021-03-12
Q3 2020 $105K -$428K -80.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $105K -$383K -78.5% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $261K -$228K -46.6% Mar 31, 2020 10-Q 2020-06-19
Q4 2019 $117K Dec 31, 2019 10-K 2020-02-27
Q3 2019 $533K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $488K Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $489K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.